Emergent Biosolutions EBS Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's preferred stock, par or stated value per share?
- Emergent Biosolutions (EBS) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Emergent Biosolutions's preferred stock, par or stated value per share changed year-over-year?
- Emergent Biosolutions's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Emergent Biosolutions's preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Emergent Biosolutions's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.